Caladrius Biosciences To Host 2017 Second Quarter Results Conference Call On August 10, 2017 At 4:30 P.M. Eastern Time

Published: Aug 03, 2017

BASKING RIDGE, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiology indications, announces that the Company will release financial results for the three and six months ended June 30, 2017 on Thursday, August 10, 2017.

Caladrius’ management will host a conference call for the investment community beginning at 4:30 p.m. ET on Thursday, August 10, 2017, to discuss the financial results, provide a company update and answer questions.

Back to news